DLF Limited (NSE:DLF)

Sage Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 5, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,933,095	1,684,450	2,220,355	882,944	941,732	710,538
Market Cap Growth	1.58%	-24.14%	151.47%	-6.24%	32.54%	108.84%
Enterprise Value	1,864,156	1,705,884	2,217,211	907,174	983,960	745,479
Last Close Price	780.95	675.56	885.43	349.34	369.69	277.13
PE Ratio	43.13	38.57	81.42	43.37	62.75	64.97
Forward PE	45.16	40.91	68.95	31.39	42.95	43.41
PS Ratio	20.68	21.07	34.55	15.50	16.47	13.12
PB Ratio	4.54	3.96	5.63	2.34	2.59	2.01
P/TBV Ratio	4.66	4.06	5.79	2.41	2.67	2.07
P/FCF Ratio	-	32.78	91.63	38.20	35.10	49.12
P/OCF Ratio	-	32.17	87.46	37.17	33.26	48.66
PEG Ratio	1.15	1.48	1.68	0.85	-	-
EV/Sales Ratio	19.94	21.34	34.50	15.93	17.21	13.77
EV/EBITDA Ratio	46.47	80.86	105.17	53.08	56.99	51.38
EV/EBIT Ratio	48.27	86.32	112.21	57.51	61.69	56.91
EV/FCF Ratio	-	33.19	91.50	39.25	36.67	51.53
Debt / Equity Ratio	0.10	0.10	0.12	0.09	0.12	0.20
Debt / EBITDA Ratio	1.81	1.93	2.28	1.93	2.40	4.69
Debt / FCF Ratio	-	0.80	2.00	1.44	1.56	4.77
Asset Turnover	-	0.12	0.11	0.11	0.11	0.10
Inventory Turnover	-	0.18	0.14	0.12	0.13	0.13
Quick Ratio	-	0.56	0.56	0.37	0.23	0.27
Current Ratio	-	1.85	2.30	2.30	2.32	2.08
Return on Equity (ROE)	-	10.65%	7.06%	5.49%	4.18%	3.10%
Return on Assets (ROA)	-	1.90%	2.16%	1.85%	1.86%	1.46%
Return on Capital (ROIC)	2.91%	2.72%	2.90%	2.42%	2.41%	1.93%
Return on Capital Employed (ROCE)	-	4.20%	4.30%	3.70%	3.80%	3.10%
Earnings Yield	2.32%	2.59%	1.23%	2.31%	1.59%	1.54%
FCF Yield	-	3.05%	1.09%	2.62%	2.85%	2.04%
Dividend Yield	0.76%	0.89%	0.56%	1.15%	0.81%	0.72%
Payout Ratio	-	28.24%	36.19%	36.49%	33.11%	18.17%
Buyback Yield / Dilution	-0.03%	-	-	-	-	-2.11%
Total Shareholder Return	0.72%	0.89%	0.56%	1.15%	0.81%	-1.39%

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.